噻奈普汀 (Chinese Wikipedia)

Analysis of information sources in references of the Wikipedia article "噻奈普汀" in Chinese language version.

refsWebsite

Global rank Chinese rank

10web.archive.org

1^st place

10nih.gov

4^th place

5^th place

7doi.org

2^nd place

23^rd place

3semanticscholar.org

11^th place

332^nd place

2books.google.com

3^rd place

8^th place

1drugs.com

399^th place

208^th place

1springer.com

274^th place

320^th place

1legislation.gov.au

6,658^th place

low place

1dropboxusercontent.com

low place

1archive.org

6^th place

4^th place

1medicalresearchjournal.org

low place

1worldcat.org

5^th place

12^th place

1medicinescomplete.com

low place

9,960^th place

1who.int

195^th place

179^th place

1scadarmenia.org

low place

archive.org

Berridge KC, Kringelbach ML. Affective neuroscience of pleasure: reward in humans and animals. Psychopharmacology. August 2008, 199 (3): 457–80. PMC 3004012 . PMID 18311558. doi:10.1007/s00213-008-1099-6.

books.google.com

Elks J. The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. 14 November 2014: 1195– [2022-03-03]. ISBN 978-1-4757-2085-3. （原始内容存档于2020-08-31）.
Index Nominum 2000: International Drug Directory. Taylor & Francis. 2000: 1024– [2022-03-03]. ISBN 978-3-88763-075-1. （原始内容存档于2020-09-07）.

doi.org

Wagstaff AJ, Ormrod D, Spencer CM. Tianeptine: a review of its use in depressive disorders. CNS Drugs. March 2001, 15 (3): 231–59. PMID 11463130. doi:10.2165/00023210-200115030-00006.
Carlhant D, Le Garrec J, Guedes Y, Salvadori C, Mottier D, Riche C. Pharmacokinetics and bioavailability of tianeptine in the elderly. Drug Investigation. September 1990, 2 (3): 167–172. S2CID 56502717. doi:10.1007/BF03259191.
Kasper S, McEwen BS. Neurobiological and clinical effects of the antidepressant tianeptine. CNS Drugs. 2008, 22 (1): 15–26. PMID 18072812. S2CID 30330824. doi:10.2165/00023210-200822010-00002.
Gassaway MM, Rives ML, Kruegel AC, Javitch JA, Sames D. The atypical antidepressant and neurorestorative agent tianeptine is a μ-opioid receptor agonist. Translational Psychiatry. July 2014, 4 (7): e411. PMC 4119213 . PMID 25026323. doi:10.1038/tp.2014.30.
Berridge KC, Kringelbach ML. Affective neuroscience of pleasure: reward in humans and animals. Psychopharmacology. August 2008, 199 (3): 457–80. PMC 3004012 . PMID 18311558. doi:10.1007/s00213-008-1099-6.
El Zahran T, Schier J, Glidden E, Kieszak S, Law R, Bottei E, et al. Characteristics of Tianeptine Exposures Reported to the National Poison Data System - United States, 2000-2017. MMWR. Morbidity and Mortality Weekly Report. August 2018, 67 (30): 815–818. PMC 6072055 . PMID 30070980. doi:10.15585/mmwr.mm6730a2.
Lauhan R, Hsu A, Alam A, Beizai K. Tianeptine Abuse and Dependence: Case Report and Literature Review. Psychosomatics. November 2018, 59 (6): 547–553. PMID 30149933. S2CID 52099752. doi:10.1016/j.psym.2018.07.006.

dropboxusercontent.com

dl.dropboxusercontent.com

Defrance R, Marey C, Kamoun A. Antidepressant and anxiolytic activities of tianeptine: an overview of clinical trials (PDF). Clinical Neuropharmacology. 1988, 11 (Suppl 2): S74–82. PMID 2902922. （原始内容 (PDF)存档于4 April 2016）.

drugs.com

Tianeptine. [2022-03-03]. （原始内容存档于2012-01-25）.

legislation.gov.au

存档副本. [2022-03-03]. （原始内容存档于2020-12-13）.

medicalresearchjournal.org

Akiki T. The etiology of depression and the therapeutic implications. Glob. J. Med. Res. [2022-03-03]. ISSN 2249-4618. （原始内容存档于2016-11-03）.

medicinescomplete.com

Tianeptine Sodium. Martindale: The Complete Drug Reference (London, UK: Pharmaceutical Press). 5 December 2011 [2 December 2013].

nih.gov

ncbi.nlm.nih.gov

Royer RJ, Albin H, Barrucand D, Salvadori-Failler C, Kamoun A. Pharmacokinetic and metabolic parameters of tianeptine in healthy volunteers and in populations with risk factors. Clinical Neuropharmacology. 1988, 11 (Suppl 2): S90–6. PMID 3180120.
Wagstaff AJ, Ormrod D, Spencer CM. Tianeptine: a review of its use in depressive disorders. CNS Drugs. March 2001, 15 (3): 231–59. PMID 11463130. doi:10.2165/00023210-200115030-00006.
Defrance R, Marey C, Kamoun A. Antidepressant and anxiolytic activities of tianeptine: an overview of clinical trials (PDF). Clinical Neuropharmacology. 1988, 11 (Suppl 2): S74–82. PMID 2902922. （原始内容 (PDF)存档于4 April 2016）.
Kasper S, McEwen BS. Neurobiological and clinical effects of the antidepressant tianeptine. CNS Drugs. 2008, 22 (1): 15–26. PMID 18072812. S2CID 30330824. doi:10.2165/00023210-200822010-00002.
Gassaway MM, Rives ML, Kruegel AC, Javitch JA, Sames D. The atypical antidepressant and neurorestorative agent tianeptine is a μ-opioid receptor agonist. Translational Psychiatry. July 2014, 4 (7): e411. PMC 4119213 . PMID 25026323. doi:10.1038/tp.2014.30.
Berridge KC, Kringelbach ML. Affective neuroscience of pleasure: reward in humans and animals. Psychopharmacology. August 2008, 199 (3): 457–80. PMC 3004012 . PMID 18311558. doi:10.1007/s00213-008-1099-6.
El Zahran T, Schier J, Glidden E, Kieszak S, Law R, Bottei E, et al. Characteristics of Tianeptine Exposures Reported to the National Poison Data System - United States, 2000-2017. MMWR. Morbidity and Mortality Weekly Report. August 2018, 67 (30): 815–818. PMC 6072055 . PMID 30070980. doi:10.15585/mmwr.mm6730a2.
Lauhan R, Hsu A, Alam A, Beizai K. Tianeptine Abuse and Dependence: Case Report and Literature Review. Psychosomatics. November 2018, 59 (6): 547–553. PMID 30149933. S2CID 52099752. doi:10.1016/j.psym.2018.07.006.
Vadachkoria D, Gabunia L, Gambashidze K, Pkhaladze N, Kuridze N. Addictive potential of Tianeptine - the threatening reality. Georgian Medical News. September 2009, (174): 92–4 [2024-07-19]. PMID 19801742. （原始内容存档于2023-12-09）.

pubmed.ncbi.nlm.nih.gov

Vadachkoria D, Gabunia L, Gambashidze K, Pkhaladze N, Kuridze N. Addictive potential of Tianeptine - the threatening reality. Georgian Medical News. September 2009, (174): 92–4 [2024-07-19]. PMID 19801742. （原始内容存档于2023-12-09）.

scadarmenia.org

Ives R. Assessment Mission Report for the SCAD V Programme, Component on Prevention and on Media Work (PDF). 2008 [4 November 2008]. （原始内容 (PDF)存档于1 December 2010）.

semanticscholar.org

api.semanticscholar.org

Carlhant D, Le Garrec J, Guedes Y, Salvadori C, Mottier D, Riche C. Pharmacokinetics and bioavailability of tianeptine in the elderly. Drug Investigation. September 1990, 2 (3): 167–172. S2CID 56502717. doi:10.1007/BF03259191.
Kasper S, McEwen BS. Neurobiological and clinical effects of the antidepressant tianeptine. CNS Drugs. 2008, 22 (1): 15–26. PMID 18072812. S2CID 30330824. doi:10.2165/00023210-200822010-00002.
Lauhan R, Hsu A, Alam A, Beizai K. Tianeptine Abuse and Dependence: Case Report and Literature Review. Psychosomatics. November 2018, 59 (6): 547–553. PMID 30149933. S2CID 52099752. doi:10.1016/j.psym.2018.07.006.

springer.com

adisinsight.springer.com

Tianeptine – AdisInsight. AdisInsight. Springer. [31 January 2016]. （原始内容存档于2022-03-03）.

web.archive.org

Elks J. The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. 14 November 2014: 1195– [2022-03-03]. ISBN 978-1-4757-2085-3. （原始内容存档于2020-08-31）.
Index Nominum 2000: International Drug Directory. Taylor & Francis. 2000: 1024– [2022-03-03]. ISBN 978-3-88763-075-1. （原始内容存档于2020-09-07）.
Tianeptine. [2022-03-03]. （原始内容存档于2012-01-25）.
Tianeptine – AdisInsight. AdisInsight. Springer. [31 January 2016]. （原始内容存档于2022-03-03）.
存档副本. [2022-03-03]. （原始内容存档于2020-12-13）.
Defrance R, Marey C, Kamoun A. Antidepressant and anxiolytic activities of tianeptine: an overview of clinical trials (PDF). Clinical Neuropharmacology. 1988, 11 (Suppl 2): S74–82. PMID 2902922. （原始内容 (PDF)存档于4 April 2016）.
Akiki T. The etiology of depression and the therapeutic implications. Glob. J. Med. Res. [2022-03-03]. ISSN 2249-4618. （原始内容存档于2016-11-03）.
Vadachkoria D, Gabunia L, Gambashidze K, Pkhaladze N, Kuridze N. Addictive potential of Tianeptine - the threatening reality. Georgian Medical News. September 2009, (174): 92–4 [2024-07-19]. PMID 19801742. （原始内容存档于2023-12-09）.
World Health Organization. Pharmaceuticals: Restrictions in use and availability, March 2001 (PDF). 2001 [24 July 2008]. （原始内容 (PDF)存档于17 November 2008）.
Ives R. Assessment Mission Report for the SCAD V Programme, Component on Prevention and on Media Work (PDF). 2008 [4 November 2008]. （原始内容 (PDF)存档于1 December 2010）.

who.int

World Health Organization. Pharmaceuticals: Restrictions in use and availability, March 2001 (PDF). 2001 [24 July 2008]. （原始内容 (PDF)存档于17 November 2008）.

worldcat.org

Akiki T. The etiology of depression and the therapeutic implications. Glob. J. Med. Res. [2022-03-03]. ISSN 2249-4618. （原始内容存档于2016-11-03）.